Artificial intelligence (AI) is rapidly transforming clinical trials by dramatically reducing timelines and costs, accelerating patient-centered drug development and creating more resilient and ...

The Institute of Medicine has released the results of a public workshop led by its Roundtable on Value & Science-Driven Health Care and the Forum on Drug Discovery, Development and Translation on ...

Mayo Clinic researchers have developed a new way to predict whether existing drugs could be repurposed to treat heart failure, one of the world's most pressing health challenges. By combining advanced ...

Community-based clinical trials hold much promise for modernizing the way we develop new treatments for the patients who need them. Their community-embedded design can improve diversity, increasing ...